Filed: 11/14/2025ACC: 0001940272-25-000008
📋 What this filing means
ADAR1 CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 203 equity positions with a total reported market value of $1.06B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
203
Positions
$1.06B
Total AUM (reported)
79.17M
Total Shares
Allocation by class
COM$525.33M49.3%
SPONSORED ADS$128.94M12.1%
COM NEW$92.70M8.7%
SHS$92.69M8.7%
TR UNIT$66.74M6.3%
ALPHA ARCH 1-3$38.39M3.6%
ADR$29.44M2.8%
Portfolio Concentration
Top 3$266.68M25.1%
4–10$279.91M26.3%
11–25$196.08M18.4%
Rest$321.90M30.2%
Top 3 weight
25.1%
Top 10 weight
51.3%
Voting Authority Distribution
Total shares with voting rights: 78M
Sole
Full voting authority
78M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole203
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings203
Rows:
ABIVAX SA
SOLEShares1.35M
TypeSH
Market value$114.69M
10.77%
Sole
1.35M
Shared
0.00
None
0.00
KEROS THERAPEUTICS INC
SOLEShares5.39M
TypeSH
Market value$85.26M
8.01%
Sole
5.39M
Shared
0.00
None
0.00
SPDR S&P 500 ETF TR
SOLEShares100.18K
TypeSH
Market value$66.74M
6.27%
Sole
100.18K
Shared
0.00
None
0.00
PROTAGONIST THERAPEUTICS INC
SOLEShares989.18K
TypeSH
Market value$65.71M
6.17%
Sole
989.18K
Shared
0.00
None
0.00
ROIVANT SCIENCES LTD
SOLEShares3.35M
TypeSH
Market value$50.65M
4.76%
Sole
3.35M
Shared
0.00
None
0.00
EA SERIES TRUST
SOLEShares337.13K
TypeSH
Market value$38.39M
3.61%
Sole
337.13K
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares2.24M
TypeSH
Market value$36.14M
3.39%
Sole
2.24M
Shared
0.00
None
0.00
89BIO INC
SOLEShares2.11M
TypeSH
Market value$31.06M
2.92%
Sole
2.11M
Shared
0.00
None
0.00
ZAI LAB LTD
SOLEShares868.78K
TypeSH
Market value$29.44M
2.77%
Sole
868.78K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares518.92K
TypeSH
Market value$28.52M
2.68%
Sole
518.92K
Shared
0.00
None
0.00
SEPTERNA INC
SOLEShares1.18M
TypeSH
Market value$22.13M
2.08%
Sole
1.18M
Shared
0.00
None
0.00
UNIQURE NV
SOLEShares333.32K
TypeSH
Market value$19.46M
1.83%
Sole
133.32K
Shared
0.00
None
0.00
PROTHENA CORP PLC
SOLEShares1.47M
TypeSH
Market value$14.34M
1.35%
Sole
1.47M
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares273.41K
TypeSH
Market value$14.20M
1.33%
Sole
273.41K
Shared
0.00
None
0.00
ARBUTUS BIOPHARMA CORP
SOLEShares2.90M
TypeSH
Market value$13.18M
1.24%
Sole
2.90M
Shared
0.00
None
0.00
RAPT THERAPEUTICS INC
SOLEShares507.77K
TypeSH
Market value$13.10M
1.23%
Sole
507.77K
Shared
0.00
None
0.00
CYTOMX THERAPEUTICS INC
SOLEShares4.05M
TypeSH
Market value$12.90M
1.21%
Sole
4.05M
Shared
0.00
None
0.00
SPDR SERIES TRUST
SOLEShares135.59K
TypeSH
Market value$12.44M
1.17%
Sole
135.59K
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares866.20K
TypeSH
Market value$11.77M
1.11%
Sole
866.20K
Shared
0.00
None
0.00
BIOAGE LABS INC
SOLEShares1.88M
TypeSH
Market value$11.05M
1.04%
Sole
1.88M
Shared
0.00
None
0.00
MONOPAR THERAPEUTICS INC
SOLEShares130K
TypeSH
Market value$10.62M
1.00%
Sole
130K
Shared
0.00
None
0.00
AA MISSION ACQUISITION CORP
SOLEShares983.45K
TypeSH
Market value$10.35M
0.97%
Sole
578.36K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares248.37K
TypeSH
Market value$10.34M
0.97%
Sole
248.37K
Shared
0.00
None
0.00
LEXEO THERAPEUTICS INC
SOLEShares1.53M
TypeSH
Market value$10.17M
0.96%
Sole
1.53M
Shared
0.00
None
0.00
CG ONCOLOGY INC
SOLEShares248.92K
TypeSH
Market value$10.03M
0.94%
Sole
248.92K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ABIVAX SASOLE | SPONSORED ADS | 1.35M | SH | $114.69M 10.77% | 1.35M | 0.00 | 0.00 |
KEROS THERAPEUTICS INCSOLE | COM | 5.39M | SH | $85.26M 8.01% | 5.39M | 0.00 | 0.00 |
SPDR S&P 500 ETF TRSOLE | TR UNIT | 100.18K | SH | $66.74M 6.27% | 100.18K | 0.00 | 0.00 |
PROTAGONIST THERAPEUTICS INCSOLE | COM | 989.18K | SH | $65.71M 6.17% | 989.18K | 0.00 | 0.00 |
ROIVANT SCIENCES LTDSOLE | SHS | 3.35M | SH | $50.65M 4.76% | 3.35M | 0.00 | 0.00 |
EA SERIES TRUSTSOLE | ALPHA ARCH 1-3 | 337.13K | SH | $38.39M 3.61% | 337.13K | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 2.24M | SH | $36.14M 3.39% | 2.24M | 0.00 | 0.00 |
89BIO INCSOLE | COM | 2.11M | SH | $31.06M 2.92% | 2.11M | 0.00 | 0.00 |
ZAI LAB LTDSOLE | ADR | 868.78K | SH | $29.44M 2.77% | 868.78K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 518.92K | SH | $28.52M 2.68% | 518.92K | 0.00 | 0.00 |
SEPTERNA INCSOLE | COM | 1.18M | SH | $22.13M 2.08% | 1.18M | 0.00 | 0.00 |
UNIQURE NVSOLE | SHS | 333.32K | SH | $19.46M 1.83% | 133.32K | 0.00 | 0.00 |
PROTHENA CORP PLCSOLE | SHS | 1.47M | SH | $14.34M 1.35% | 1.47M | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 273.41K | SH | $14.20M 1.33% | 273.41K | 0.00 | 0.00 |
ARBUTUS BIOPHARMA CORPSOLE | COM | 2.90M | SH | $13.18M 1.24% | 2.90M | 0.00 | 0.00 |
RAPT THERAPEUTICS INCSOLE | COM NEW | 507.77K | SH | $13.10M 1.23% | 507.77K | 0.00 | 0.00 |
CYTOMX THERAPEUTICS INCSOLE | COM | 4.05M | SH | $12.90M 1.21% | 4.05M | 0.00 | 0.00 |
SPDR SERIES TRUSTSOLE | BLOOMBERG 1-3 MO | 135.59K | SH | $12.44M 1.17% | 135.59K | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COM | 866.20K | SH | $11.77M 1.11% | 866.20K | 0.00 | 0.00 |
BIOAGE LABS INCSOLE | COM | 1.88M | SH | $11.05M 1.04% | 1.88M | 0.00 | 0.00 |
MONOPAR THERAPEUTICS INCSOLE | COM NEW | 130K | SH | $10.62M 1.00% | 130K | 0.00 | 0.00 |
AA MISSION ACQUISITION CORPSOLE | ORD SHS CL A | 983.45K | SH | $10.35M 0.97% | 578.36K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 248.37K | SH | $10.34M 0.97% | 248.37K | 0.00 | 0.00 |
LEXEO THERAPEUTICS INCSOLE | COM | 1.53M | SH | $10.17M 0.96% | 1.53M | 0.00 | 0.00 |
CG ONCOLOGY INCSOLE | COM | 248.92K | SH | $10.03M 0.94% | 248.92K | 0.00 | 0.00 |
Page 1 of 9
…